Lowering Your Risk for Disease
Nutritionists are concerned about the impact of dietary consumption on cancer risk. 25% of cancer cases in the US could be prevented by improving nutrition, particularly being overweight or obese,…
New Vit. D, Omega-3 Findings
A two-year follow-up study found that while the protection from daily vitamin D supplementation for reducing risk of autoimmune disease disappeared after the supplement was discontinued, the benefits of daily…
What Are Happy Hormones? Ways To Naturally Improve Them In Your Body
Happy hormones, also known as neurotransmitters, play a significant role in regulating mood, pleasure, and overall well-being. The four main happy hormones are dopamine, serotonin, oxytocin, and endorphins. Dopamine is…
Same-day combo of chemical peels and neurotoxins safe and effective cosmetic therapy for photoaging
A same-day combination of chemical peels and neurotoxins is a safe and effective cosmetic therapy for treating photoaging. This combination treatment helps to improve the appearance of aging skin, reducing…
Eli Lilly Fatty Liver Drug Posts Promising Early Data, But Field Is Still Competitive
Eli Lilly's metabolic disorder medication tirzepatide, which is approved for type 2 diabetes and weight management, has shown positive early clinical data for treating fatty liver disease (NASH) with no…
Skin Manifestations of Systemic Cancers
Dermatologists play an important role in identifying and detecting various types of cancer before they reach later stages. Paraneoplastic diseases are clinical disorders that manifest in association with underlying malignancies.…
Intellihealth appoints executive VP of clinical operations and more digital health hires
Healthcare technology company Intellihealth has hired Annie Lorenzo as its executive vice president of clinical operations. She will manage the clinical operations personnel at Flyte Medical, an affiliate of Intellihealth.…
Halfway Through ‘Unwinding,’ Medicaid Enrollment Is Down About 10 Million
Enrollment in Medicaid has fallen by about 9.5 million people since last April due to procedural issues, leaving it on track to cover about 71 million people. The Biden administration…
House panel passes PBM reforms for sliver of commercial market
The House panel passed a bipartisan bill to ban drug middlemen from charging fees based on drug list prices, representing Congress' first PBM reform efforts. The bill, introduced by Rep.…
Purdue Pharma’s “predatory and deceptive” advertiser Publicis pays $350m to US states
Publicis Groupe, an advertising firm that worked with opioid maker Purdue Pharma, will pay a $350 million settlement to all 50 US states. This is to resolve allegations of using…